The Bank of Kentucky Financial Corporation (Nasdaq:BKYF) announced that its subsidiary, The Bank of Kentucky, Inc. (”The Bank of Kentucky”), executed a purchase and assumption agreement with the United Kentucky Bank of Pendleton County, Inc. (”United Kentucky Bank”) on June 30, 2011. Under the terms of the purchase and assumption agreement, The Bank of Kentucky will assume approximately $26 million of deposit liabilities, as well as other expressly identified liabilities, and purchase certain assets, including United Kentucky Bank’s Falmouth, Kentucky office and ATM and $14 million in selected loans, from United Kentucky Bank.

The Bank of Kentucky Financial Corporation operates as the holding company for the Bank of Kentucky, Inc., which provides various commercial banking and consumer banking services.

*****************************************************

Power3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s disease, is a progressive neuromuscular disease that weakens and eventually destroys motor neurons (components of the nervous system that connect the brain with the skeletal muscles).

Upper motor neurons are located in the cerebral cortex of the brain and conduct impulses from the motor cortex to nerves in the brain or the spinal cord. Lower motor neurons are peripheral neurons that originate in the spinal cord and conduct impulses to the skeletal muscles. Skeletal muscles are involved with voluntary movements, such as walking and talking. The lower motor neurons transmit the command to move from the brain to the skeletal muscles, which respond by contracting.

The NuroPro Blood Test is Power3 Medical’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

*****************************************************

People’s United Financial Inc. (Nasdaq:PBCT) announced that it has completed its acquisition of Danvers Bancorp, Inc., a $2.9 billion bank holding company based in Danvers, Massachusetts. Danvers Bancorp’s sole subsidiary, Danversbank, has 28 branches in the Greater Boston area. The total consideration paid by People’s United will be comprised of approximately 18.5 million shares of common stock and $214.5 million in cash. “We are pleased to welcome our new customers and employees to People’s United Bank as we expand and deepen relationships in the greater Boston market, the nation’s 10th largest MSA,” said Jack Barnes, President and Chief Executive Officer of People’s United Bank. “As the largest bank headquartered in New England, we look forward to offering increased lending resources and additional products and services to our new customers in New England’s largest market.

People’s United Financial, Inc. operates as the bank holding company for People’s United Bank that provides commercial banking, retail and business banking, and wealth management services to individual, corporate, and municipal customers.

*****************************************************

Good Times Restaurants Inc. (Nasdaq:GTIM) announced its eleventh consecutive month of same store sales increases with June sales increasing 5.1% from the prior year and that its same store sales for the third quarter of fiscal 2011 increased 6.1%. Year to date for the first nine months of the fiscal year same store sales have increased 8.3%. Commenting on the sales improvement, President & CEO, Boyd Hoback said, “While there has been some rising of the tide from the macro-economic environment, we continue to see good results from our promotional and product strategy, with the focus on fresh, handcrafted food and products available only at Good Times. This has favorably impacted our average check per transaction and helped to mitigate some of the commodity cost increases and margin loss.”

Good Times Restaurants, Inc., through its subsidiary, Good Times Drive Thru Inc., engages in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants under the Good Times Burgers & Frozen Custard name primarily in Colorado.

*****************************************************

AmSurg Corp. (Nasdaq:AMSG) announced it will provide an on-line Web simulcast and rebroadcast of its 2011 second quarter earnings release conference call. The live broadcast of AmSurg Corp.’s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations, or at http://www.earnings.com. The call is scheduled to begin at 5:00 p.m. Eastern Time on Thursday, July 21, 2011. The on-line replay will follow shortly after the call and continue for 30 days.

AmSurg Corp., through its wholly owned subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physicians in the United States.

*****************************************************

Advanced Energy Industries, Inc. (Nasdaq:AEIS) updated its outlook for the quarter ended June 30, 2011. Based on preliminary financial data, the company now expects to report revenue between $137 million and $140 million for the second quarter of 2011, below the range of $148 million to $160 million it projected on May 2, 2011, and earnings at the low end of, or slightly lower than the range it projected on May 2, 2011.

Advanced Energy Industries, Inc., together with its subsidiaries, designs, manufactures, sells, and supports industrial power conversion products that transform power into various usable forms.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Power3 Medical Products, Inc (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Breast cancer can have a number of symptoms but usually shows as a lump or thickening in the breast tissue (although most breast lumps are not cancerous). If cancer is detected at an early stage, it can be treated before it spreads to nearby parts of the body.

A woman’s breasts are made up of fat, connective tissue and thousands of tiny glands, known as lobules, which produce milk. If a woman has a baby, the milk is delivered to the nipple through tiny tubes called ducts, which allow her to breastfeed.

Our bodies are made up of billions of tiny cells. Normally, cells grow and multiply in an orderly way. New cells are only made when and where they are needed. In cancer, this orderly process goes wrong and cells begin to grow and multiply uncontrollably.

Power3 Medical Products, Inc is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:

Breast Cancer
Alzheimer’s Disease
ALS (Lou Gehrig’s Disease)
Parkinson’s Disease
Chemotherapeutic Drug Resistance
Leukemia
Gastrointestinal Disease
Metabolic Syndrome

For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com

*****************************************************

Hasbro Inc. (Nasdaq:HAS) brings action and adventure to the construction aisle in July with the introduction of the KRE-O brand. The KRE-O brand allows builders and Hasbro fans ages 6 and up to enjoy and create with popular Hasbro brands, like the TRANSFORMERS brand beginning in 2011 and many other Hasbro brands planned for the future, in a construction play pattern like never before. With the debut of the Transformers: Dark of the Moon movie from Paramount Pictures this week and the animated series Transformers Prime currently airing on The Hub television network, KRE-O TRANSFORMERS sets are another exciting new way for kids and fans to experience the iconic TRANSFORMERS brand this year.

Hasbro, Inc. engages in the design, manufacture, and marketing of games and toys. The company principally provides childrens and family leisure time and entertainment products and services.

*****************************************************

Luminex Corporation (Nasdaq:LMNX) announced the completion of its acquisition of privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications, for $34 million in cash. Luminex expects the EraGen acquisition will add between $5 million and $7 million to 2011 consolidated revenue. On a GAAP basis, inclusive of purchase related costs, Luminex expects this acquisition to be dilutive in 2011 and accretive to earnings in 2012.

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the life sciences and diagnostic industries in the United States.

*****************************************************

Potlatch Corporation (Nasdaq:PCH) will release second quarter 2011 earnings on Monday, July 25, 2011, before the market opens. A live conference call and webcast will follow hosted by Michael J. Covey, chairman, president and chief executive officer, and Eric J. Cremers, vice president, finance and chief financial officer at 9 a.m. Pacific Time (noon Eastern Time). Investors may access the webcast at www.potlatchcorp.com by clicking on the Investor Resources link or by conference call at 1-866-393-8403 for U.S./Canada and 1-706-679-7929 for international callers. Participants will be asked to provide conference I.D. number 80396087.

Potlatch Corporation operates as a real estate investment trust (REIT) that owns and manages timberlands located in Arkansas, Idaho, Minnesota and Wisconsin in the United States.

*****************************************************

CBOE Holdings, Inc. (Nasdaq:CBOE) reported that June trading volume for options on the Chicago Board Options Exchange (CBOE) and C2 Options Exchange (C2), the company’s alternative all-electronic market, combined, totaled 99.4 million contracts; average daily volume (ADV) was 4.5 million contracts, up 10 percent from June 2010. C2 and CBOE Futures Exchange (CFE) achieved their busiest months ever in June, with monthly ADV exceeding 200,000 contracts and 50,000 contracts, respectively, for the first time.

CBOE Holdings, Inc. intends to operate as the holding company for Chicago Board Options Exchange (CBOE), which operates as an organized marketplace for the trade of standardized, listed options on equity securities.

*****************************************************

First Niagara Financial Group Inc. (Nasdaq:FNFG) announced that it will release 2011 second quarter earnings before the market opens on Thursday, July 21, 2011. A conference call will follow at 11:00 a.m. Eastern Time, in which management will discuss the Company’s financial results and business strategy, followed by a question-and-answer session. Those wishing to participate in the call may dial toll-free 1-877-709-8150 . A replay of the call will be available until August 4, 2011 by dialing 1-877-660-6853 , Account 240, Passcode 374802.

First Niagara Financial Group, Inc. operates as the holding company for First Niagara Bank, N.A. that provides retail and commercial banking, and other financial services to individuals, families, and businesses.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Zumiez Inc. made our debut in the Seattle area in 1978, with a single store location at Northgate Mall. Now we have grown, and currently have over 400 retail stores that reach across the United States. We do what others have only dreamed of! We provide you with cutting edge clothing, footwear, accessories, DVDs, hard goods for skate and snow for active lifestyles. Everything we do revolves around the customer—you are the heart of our company.

We love and support the skate and snow industries that our customers live and ride for. With the success of our retail Zumiez shops, we’ve opened our online store for the world to experience, ZUMIEZ.COM! We want our customers to seek us, either shopping from their recliner at home or roaming through their favorite Zumiez store location. So shop, download and explore the world of Zumiez!

Net Sales Increased 16.8% to $43.5 Million; June 2011 Comparable Store Sales Increased 9.8%

Zumiez Inc. (NASDAQ:ZUMZ), a leading specialty retailer of action sports related apparel, footwear, equipment and accessories, announced that total net sales for the five-week period ended July 2, 2011 increased 16.8% to $43.5 million, compared to $37.2 million for the five-week period ended July 3, 2010. The Company’s comparable store sales increased 9.8% for the five-week period, on top of a comparable store sales increase of 10.9% in the year ago period.

To hear the Zumiez prerecorded June sales message, please dial (585) 295-6795 or (866) 862-7693 (no passcode is required).

Zumiez is a leading specialty retailer of action sports related apparel, footwear, equipment and accessories. Our stores cater to young men and women between ages 12-24, focusing on skateboarding, surfing, snowboarding, motocross and BMX. As of July 2, 2011 we operated 415 stores in the United States and 3 stores in Canada, which are primarily located in shopping malls, and our web site address is www.zumiez.com.

*************************************

AllianceBernstein National Municipal Income Fund, Inc. (NYSE:AFB), a closed-end management investment company, declared on this date, June 28, 2011, a monthly distribution of $0.0775 per share of Common Stock, payable July 22, 2011 to shareholders of record at the close of business on July 8, 2011. AllianceBernstein National Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.

AllianceBernstein National Municipal Income Fund, Inc is a closed-ended fixed income mutual fund launched and managed by AllianceBernstein L.P.

**************************************************************

Power3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

The NuroPro Blood Test is Power3 Medical’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Parkinson’s disease develops as a result of the inability of nerves to carry signals within the brain. Normally a chemical called dopamine allows nerves in the brain that control movement to transmit signals to each other. As the cells that make dopamine die Parkinson’s disease progresses. The cause of cell death leading to Parkinson’s disease remains a mystery although many theories have been put forward.

The primary problem in Parkinson’s disease is a lack of the chemical called dopamine. Therefore, most of the medications used to treat the condition are aimed at replacing this chemical.

The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

**************************************************************

AZZ Incorporated (NYSE:AZZ) announced unaudited financial results for the first quarter ended May 31, 2011. Revenues for the first quarter were $114.3 million compared to $77.5 million for the same quarter last year, an increase of 48 percent. Net income for the quarter was $9.5 million, or $0.75 per diluted share, compared to net income of $6.4 million, or $0.51 per diluted share, in last year’s first fiscal quarter.

AZZ Incorporated manufactures electrical equipment and components for power generation, transmission and distribution, and industrial markets primarily in the United States and Canada.

**************************************************************

Teekay Corporation (NYSE:TK) announced it has signed a memorandum of understanding (MOU) with A2SEA A/S (A2SEA) to jointly develop an innovative vessel design for the installation of offshore wind foundations. A2SEA is a leading service provider to the offshore wind sector.

Teekay Corporation provides crude oil and petroleum product transportation services in Bermuda and internationally.

**************************************************************

Chemtura Corporation (NYSE:CHMT) announced it will issue its 2011 Second Quarter earnings release and file its Quarterly Report on Form 10-Q on Wednesday, August 3, 2011 after the market closes. The company will host a teleconference to review these results on Thursday, August 4, 2011, at 9:00 AM (EDT). Copies of the release, as well as informational slides, and a webcast of the teleconference will be available on the Investor Relations section of the company’s website at www.chemtura.com.

Chemtura Corporation, together with its subsidiaries, engages in the manufacture and sale of specialty chemical solutions and consumer products worldwide.

**************************************************************

Peabody Energy Corp. (NYSE:BTU) confirmed that the Government of Mongolia has selected Peabody to be part of a global energy consortium to develop the Tavan Tolgoi coking coal reserve in the South Gobi region. Peabody continues to work with the government and other parties to reach agreement on definitive terms and conditions. Agreements would then be submitted for consideration and approval by government agencies and Parliament.

Peabody Energy Corporation, through its subsidiaries, engages in the exploration, mining, and production of coal.
**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Power3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:

Breast Cancer
Alzheimer’s Disease
ALS (Lou Gehrig’s Disease)
Parkinson’s Disease
Chemotherapeutic Drug Resistance
Leukemia
Gastrointestinal Disease
Metabolic Syndrome

There are several categories of risk factors that can cause breast cancer, but the way in which these factors transform healthy cells into cancerous cells is not entirely known. These categories of risk factors include:

Age and Gender: Age represents a significant factor for breast cancer and statistics show that a high percentage of breast cancer cases (77% of new cancer cases and 84% of breast cancer deaths) occur in women age 50 and older.

Genetic Factors and Family History of Breast Cancer: For many years, researchers noticed that patients that develop cancer have a family history of breast cancer. The latest clinical trials and research shows that this genetic breast cancer tendency that runs in families can be explained by the structure of DNA. DNA is a chemical code that carries all the instructions needed for the normal functioning of nearly every cell of the body. Therefor, certain changes in DNA structure were noticed to be responsible with changes in normal breast cells that become cancerous.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

**************************************************************

WellPoint Inc. (NYSE:WLP) announced that Robert L. Dixon, Jr. has been named to its Board of Directors. Dixon has a proven track record as a leader, having served on the executive staff of two major international corporations. Currently Senior Vice President and Global Chief Information Officer at PepsiCo, Inc., Dixon is utilizing his decades of experience to lead a global team in business and information solutions (BIS), which encompasses all global information technology and key partnerships on the enterprise business process transformation.

WellPoint, Inc., through its subsidiaries, operates as a health benefits company in the United States. It offers various network-based managed care plans to large and small employer, individual, Medicaid, and senior markets.

**************************************************************

DigitalGlobe, Inc. (NYSE:DGI) , a leading global provider of high-resolution earth imagery solutions, said that California’s Stanislaus County has contracted to use its Precision Aerial Imagery to monitor changes and manage government projects across the Central Valley county’s 1,500 square mile (3,900 square kilometer) area. DigitalGlobe’s Precision Aerial product delivers the industry’s first high-quality, wall-to-wall collection of 30 cm natural color (RGB) and 60 cm color infrared (CIR) aerial orthomosaics covering 10 million square kilometers (four million square miles) across the contiguous United States and Western Europe. Through an agreement with Microsoft, premium quality imagery is acquired exclusively using Microsoft’s UltraCamG digital imaging technology to provide comprehensive coverage with industry leading accuracy, quality and aesthetics.

DigitalGlobe, Inc. provides commercial earth imagery products and solutions. The company collects its imagery products and services via its three high-resolution imagery satellites.

**************************************************************

Hospira Inc. (NYSE:HSP) announced its support for North Carolina’s new law establishing a statewide surveillance and reporting system for 14 specified healthcare-associated infections (HAIs). The legislation, known as the Model Healthcare-Associated Infections Law, has become effective and institutions have until Dec. 31 to comply with its provisions. It specifies rules for a statewide reporting and surveillance system emphasizing a particular preference for electronic surveillance. The legislation is supported by the North Carolina Hospital Association, the North Carolina Division of Public Health and healthcare facilities throughout the state.

Hospira, Inc., a specialty pharmaceutical and medication delivery company, develops, manufactures, and markets pharmaceuticals and medication delivery systems in the United States and internationally.

**************************************************************

Dynegy Inc. (NYSE:DYN) announced that Carolyn J. Burke will join Dynegy as Executive Vice President and Chief Administrative Officer, effective August 30, 2011. Carolyn will serve on Dynegy’s executive management team and report to Robert C. Flexon. As Executive Vice President and Chief Administrative Officer, Burke will be responsible for managing key corporate functions including Information Technology, Human Resources, Investor Relations and Communications. Central to Carolyn’s responsibilities will be driving improvements to Dynegy’s cost structure through the design of the Company’s work processes.

Dynegy Inc., through its subsidiaries, engages in the production and sale of electric energy, capacity, and ancillary services in the United States.

**************************************************************

ING Prime Rate Trust (NYSE:PPR), a diversified closed-end management investment company listed on the New York Stock Exchange, declared 2.50 cents per share monthly dividend on June 30, 2011 for the 30 days of June, payable on July 22, 2011 to shareholders of record on July 11, 2011. This represents the 278th consecutive monthly dividend since the Trust’s inception in May 1988.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Platinum Group Metals Ltd (AMEX:PLG) reported that its development plans for the 74% owned Western Bushveld Joint Venture (”WBJV”) Project 1 Platinum Mine are advancing on budget and within three weeks of project schedule. Construction work of approximately 30,000 man-hours, including roads, box cut excavation for the declines and site infrastructure has progressed safely with no loss time incidents.

Platinum Group Metals Ltd. engages in the exploration and development of mineral properties in Canada and South Africa.

*********************************************

PharmAthene, Inc. (AMEX:PIP) announced that the Company was added to the Russell Global Index and the Russell 3000 Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 24, 2011. The Russell 3000 Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization. The new membership lists are available at http://www.russell.com/indexes/tools-resources/reconstitution.asp. Membership in the Russell Global Index, which remains in place for one year, means automatic inclusion in the appropriate large-cap, small-cap, all-cap indexes as well as the applicable style, sector and country indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

PharmAthene, Inc., a biodefense company, together with its subsidiaries, engages in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.

*********************************************

Power3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:

Breast Cancer
Alzheimer’s Disease
ALS (Lou Gehrig’s Disease)
Parkinson’s Disease
Chemotherapeutic Drug Resistance
Leukemia
Gastrointestinal Disease
Metabolic Syndrome

Breasts are made up of fat, connective tissue and gland tissue divided into lobes. The lobes are connected to your nipple by ducts.
Most women have breasts of different sizes which look and feel different at certain times of the month, depending on their menstrual cycle. Your breasts also change during the different stages of your life, for example, after menopause, they become less full or dense.
Breast tissue goes into your armpit where there are lymph nodes. These are glands that are part of your immune system.
Breast cancer usually starts in the cells lining the ends of the lobes and in the ducts themselves. It can spread from there into the breast tissue and lymph nodes.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

*********************************************

Vista Gold Corp. (AMEX:VGZ) is pleased to announce the initial results of drilling completed at the Batman deposit during the 2010-11 program at the Mt. Todd gold project in Northern Territory, Australia. Vista is undertaking a bankable feasibility study (”BFS”) for the Mt. Todd gold project which it expects to complete late this year. In support of the BFS, the Company started drilling at the Batman deposit in 2010 and the program is ongoing at the time of this announcement. This press release contains the results of gold assays of samples taken from 10 core holes (5740 total meters drilled) from the first phase of the program.

Vista Gold Corp. and its subsidiaries engage in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.

*********************************************

New Energy Systems Group (AMEX:NEWN) announced that it has been added to the Russell Microcap Index effective June 24, 2011. Russell Investments, a leading financial services provider serving individual and institutional investors, rebalances its entire family of indexes every year to maintain true representation of global equity markets, capitalization and style. Companies are added and deleted from the various indices according to these changes. The Russell Microcap Index Fund had approximately $497 million of assets as of June 28, 2011.

New Energy Systems Group, through its subsidiaries, manufactures and distributes lithium battery shells and related products primarily in China.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).